â€” Item 14 of 25 mY war <q = Ld @ a F 33

= jon (a: [Ls c
Question Id: 106307 Previous Next Full Screen Tutorial Lab Values Notes Calculator Reverse Color Text Zoom Settings

This patient on chronic opioid therapy has adequate pain control and is attempting to decrease
the medication dose. However, she has features of physical dependence characterized by
significant withdrawal symptoms (eg, vomiting, diarrhea, lacrimation, sweating) on
discontinuation or decreased dosage.

Opioid binding to mu opioid receptors inhibits the presynaptic release of pain neurotransmitters
(eg, substance P, glutamate, calcitonin gene-related peptide). With continued use, opioids
can induce receptor down-regulation and desensitization. Subsequently, loss of receptor
activation due to reduction or cessation of the medication can cause withdrawal symptoms, as
in this patient. Management of physical dependence may require a prolonged, scheduled
taper of the medication, often with the assistance of a pain-management specialist.

(Choice A) Opioid misuse is defined as using opioids in a way that deviates from their
prescribed dosage (eg, overuse) or purpose (eq, relieving anxiety, sharing with or selling pills
to others). It also includes obtaining opioids from multiple prescribers or taking nonprescribed
controlled substances. This patient has no features of opioid misuse.

(Choice B) Opioid use disorder is characterized by uncontrolled use despite harmful
consequences (eg, social, professional). Although this patient exhibits withdrawal symptoms,
her opioid use remains controlled. Also, her primary focus is stopping opioid therapy rather

Block Time Elapse

Tutor

ck

Suspend

